{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:52:37Z","timestamp":1790146357433,"version":"4.0.1"},"reference-count":36,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":636,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ultrasound Obstet Gynecol"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1002\/uog.12551","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T17:04:46Z","timestamp":1372179886000},"page":"89-97","source":"Crossref","is-referenced-by-count":31,"title":["Are serum HE4 or ROMA scores useful to experienced examiners for improving characterization of adnexal masses after transvaginal ultrasonography?"],"prefix":"10.1002","volume":"43","author":[{"given":"J.","family":"Kaijser","sequence":"first","affiliation":[{"name":"KU Leuven Department of Development and Regeneration; Leuven Belgium"},{"name":"Department of Obstetrics and Gynecology and Leuven Cancer Institute; University Hospitals, KU Leuven; Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Van Gorp","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology; MUMC\u2009+\u2009, GROW School for Oncology and Developmental Biology; Maastricht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-E.","family":"Smet","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology and Leuven Cancer Institute; University Hospitals, KU Leuven; Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Van Holsbeke","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology and Leuven Cancer Institute; University Hospitals, KU Leuven; Leuven Belgium"},{"name":"Department of Obstetrics and Gynecology; Ziekenhuis Oost-Limburg; Genk Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sayasneh","sequence":"additional","affiliation":[{"name":"Department of Cancer and Surgery; Imperial College London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Epstein","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology; Karolinska Institute; Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Bourne","sequence":"additional","affiliation":[{"name":"KU Leuven Department of Development and Regeneration; Leuven Belgium"},{"name":"Department of Obstetrics and Gynecology and Leuven Cancer Institute; University Hospitals, KU Leuven; Leuven Belgium"},{"name":"Department of Cancer and Surgery; Imperial College London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Vergote","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology and Leuven Cancer Institute; University Hospitals, KU Leuven; Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Van Calster","sequence":"additional","affiliation":[{"name":"KU Leuven Department of Development and Regeneration; Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Timmerman","sequence":"additional","affiliation":[{"name":"KU Leuven Department of Development and Regeneration; Leuven Belgium"},{"name":"Department of Obstetrics and Gynecology and Leuven Cancer Institute; University Hospitals, KU Leuven; Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,12,4]]},"reference":[{"key":"10.1002\/uog.12551-BIB0001|uog12551-cit-0001","unstructured":"http:\/\/www.rcog.org.uk"},{"key":"10.1002\/uog.12551-BIB0002|uog12551-cit-0002","unstructured":"http:\/\/www.rcog.org.uk"},{"key":"10.1002\/uog.12551-BIB0003|uog12551-cit-0003","unstructured":"http:\/\/publications.nice.org.uk"},{"key":"10.1002\/uog.12551-BIB0004|uog12551-cit-0004","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1471-0528.1990.tb02448.x","article-title":"A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer","volume":"97","author":"Jacobs","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1002\/uog.12551-BIB0005|uog12551-cit-0005","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1002\/uog.12551-BIB0006|uog12551-cit-0006","unstructured":"US Food and Drug Administration license for ROMA http:\/\/www.accessdata.fda.gov\/SCRIPTs\/cdrh\/devicesatfda\/index.cfm?db=pmn&id=K103358"},{"key":"10.1002\/uog.12551-BIB0007|uog12551-cit-0007","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.ejca.2011.12.003","article-title":"Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses","volume":"48","author":"Van Gorp","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1002\/uog.12551-BIB0008|uog12551-cit-0008","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/jnci\/djm199","article-title":"Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125","volume":"99","author":"Van Calster","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/uog.12551-BIB0009|uog12551-cit-0009","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/uog.6415","article-title":"Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adexal masses","volume":"34","author":"Valentin","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1002\/uog.12551-BIB0010|uog12551-cit-0010","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/uog.2707","article-title":"Which extrauterine pelvic masses are difficult to correctly classify as benign or malignant on the basis of ultrasound findings, and is there a way of making a correct diagnosis?","volume":"27","author":"Valentin","year":"2006","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1002\/uog.12551-BIB0011|uog12551-cit-0011","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/uog.9030","article-title":"Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help","volume":"38","author":"Valentin","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1002\/uog.12551-BIB0012|uog12551-cit-0012","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/uog.8813","article-title":"Improving the preoperative classification of adnexal masses as benign or malignant by second-stage tests","volume":"37","author":"Daemen","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1002\/uog.12551-BIB0013|uog12551-cit-0013","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1158\/1055-9965.EPI-11-0422","article-title":"A novel approach to predict the likelihood of specific ovarian tumor pathology based on serum CA-125 a multicenter observational study","volume":"20","author":"Van Calster","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1002\/uog.12551-BIB0014|uog12551-cit-0014","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/gyno.2000.5811","article-title":"125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors","volume":"78","author":"Engelen","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1002\/uog.12551-BIB0015|uog12551-cit-0015","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1067\/mob.2000.105940","article-title":"CA 125 measurement and ultrasonography in borderline tumors of the ovary","volume":"183","author":"Gotlieb","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1002\/uog.12551-BIB0016|uog12551-cit-0016","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S1470-2045(07)70357-1","article-title":"Benign causes of increased serum CA-125 concentration","volume":"8","author":"Sevinc","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1002\/uog.12551-BIB0017|uog12551-cit-0017","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1470-2045(06)70579-4","article-title":"Proteins with whey-acidic-protein motifs and cancer","volume":"7","author":"Bouchard","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1002\/uog.12551-BIB0018|uog12551-cit-0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.12.029","article-title":"Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders","volume":"206","author":"Moore","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1002\/uog.12551-BIB0019|uog12551-cit-0019","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","article-title":"The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass","volume":"108","author":"Moore","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1002\/uog.12551-BIB0020|uog12551-cit-0020","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1515\/cclm-2011-0477","article-title":"Diagnostic value of HE4 for ovarian cancer a meta-analysis","volume":"50","author":"Yu","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"10.1002\/uog.12551-BIB0021|uog12551-cit-0021","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/sj.bjc.6606092","article-title":"HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm","volume":"104","author":"Van Gorp","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1002\/uog.12551-BIB0022|uog12551-cit-0022","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1515\/CCLM.2011.075","article-title":"The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?","volume":"49","author":"Montagnana","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"10.1002\/uog.12551-BIB0023|uog12551-cit-0023","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ygyno.2011.02.022","article-title":"No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting","volume":"121","author":"Jacob","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1002\/uog.12551-BIB0024|uog12551-cit-0024","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/1471-2407-12-258","article-title":"Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer a meta-analysis","volume":"12","author":"Li","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1002\/uog.12551-BIB0025|uog12551-cit-0025","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1046\/j.1469-0705.2000.00287.x","article-title":"Terms, definitions and measurements to describe the sonographic features of adnexal tumors a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group","volume":"16","author":"Timmerman","year":"2000","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1002\/uog.12551-BIB0026|uog12551-cit-0026","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/s-2006-933605","article-title":"European Federation of Societies for Ultrasound in Medicine and Biology. Minimum training recommendations for the practice of medical ultrasound","volume":"27","author":"Education and Practical Standards Committee","year":"2006","journal-title":"Ultraschall Med"},{"key":"10.1002\/uog.12551-BIB0027|uog12551-cit-0027","unstructured":"http:\/\/www.fdi.com\/documents\/products\/inserts\/eia\/CA125%20EIA%20400-10%20Eng,%202012-11.%20F5048,%20r7.pdf"},{"key":"10.1002\/uog.12551-BIB0028|uog12551-cit-0028","unstructured":"http:\/\/www.fdi.com\/documents\/products\/inserts\/eia\/HE4%20EIA%20404-10,%202008-09,%20r1.pdf"},{"key":"10.1002\/uog.12551-BIB0029|uog12551-cit-0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.12.028","article-title":"Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age","volume":"206","author":"Moore","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1002\/uog.12551-BIB0030|uog12551-cit-0030","volume-title":"IARC WHO Classification of tumors, No 4. Pathology and Genetics Tumours of the Breast and Female Genital Organs","author":"World Health Organization","year":"2003"},{"key":"10.1002\/uog.12551-BIB0031|uog12551-cit-0031","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7326\/0003-4819-138-1-200301070-00010","article-title":"Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative","volume":"138","author":"Bossuyt","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1002\/uog.12551-BIB0032|uog12551-cit-0032","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/uog.12323","article-title":"Improving strategies for diagnosing ovarian cancer a summary of the International Ovarian Tumor Analysis (IOTA) studies","volume":"41","author":"Kaijser","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1002\/uog.12551-BIB0033|uog12551-cit-0033","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/bjc.2011.593","article-title":"CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial","volume":"106","author":"Alexandre","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1002\/uog.12551-BIB0034|uog12551-cit-0034","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ygyno.2012.11.026","article-title":"Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: correlation with pathological outcome","volume":"128","author":"Sandri","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1002\/uog.12551-BIB0035|uog12551-cit-0035","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ygyno.2013.04.003","article-title":"A multicenter prospective external validation of the diagnostic performance of IOTA simple descriptors and rules to characterize ovarian masses","volume":"130","author":"Sayasneh","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1002\/uog.12551-BIB0036|uog12551-cit-0036","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1038\/bjc.2013.224","article-title":"Multicentre external validation of IOTA prediction models and RMI by operators with varied training","volume":"108","author":"Sayasneh","year":"2013","journal-title":"Br J Cancer"}],"container-title":["Ultrasound in Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fuog.12551","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fuog.12551","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/uog.12551\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T22:43:29Z","timestamp":1625352209000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/uog.12551"}},"subtitle":["HE4 or ROMA after ultrasound"],"short-title":[],"issued":{"date-parts":[[2013,12,4]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"URL":"https:\/\/doi.org\/10.1002\/uog.12551","archive":["Portico"],"relation":{},"ISSN":["0960-7692"],"issn-type":[{"value":"0960-7692","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12,4]]}}}